<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Pediatrics: Metabolic Syndrome Topic Collection</title>
    <link>http://archpedi.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Thu, 01 Nov 2012 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 01 Jan 2013 00:48:55 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archpedi.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archpedi.jamanetwork.com</webMaster>
    <item>
      <title>Obesity, Metabolic Syndrome, and Insulin Resistance in Urban High School Students of Minority Race/Ethnicity Obesity in Students of Minority Race/Ethnicity </title>
      <link>http://archpedi.jamanetwork.com/article.aspx?articleID=1362181</link>
      <pubDate>Thu, 01 Nov 2012 00:00:00 GMT</pubDate>
      <author>Turchiano M, Sweat V, Fierman A, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Objectives&lt;/div&gt;To determine the point prevalences of metabolic syndrome (MetS) and its components among healthy weight, overweight, and obese inner-city public high school students, to compare the prevalences of MetS when using 2 different definitions (one with the impaired fasting glucose [IFG] level and the other with a homeostasis model assessment of insulin resistance [HOMA-IR] of 3.99 or higher to define the glucose regulation component), and to compare the degree to which HOMA-IR and fasting glucose level are associated with the other MetS components.&lt;div class="boxTitle"&gt;Design&lt;/div&gt;Cross-sectional analysis.&lt;div class="boxTitle"&gt;Setting&lt;/div&gt;Two New York City public high schools, from April 2008 through August 2011.&lt;div class="boxTitle"&gt;Participants&lt;/div&gt;Convenience sample of 1185 high school youth, comprising predominantly Hispanic and African American students from low-income households, participating in The Banishing Obesity and Diabetes in Youth Project, a medical screening and education program.&lt;div class="boxTitle"&gt;Main Outcome Measures&lt;/div&gt;Prevalences of the following individual MetS components: IFG threshold, HOMA-IR, hypertension, central adiposity, hypertriglyceridemia, and low high-density lipoprotein cholesterol. Rates of MetS&lt;sub&gt;IFG&lt;/sub&gt; and MetS&lt;sub&gt;HOMA-IR&lt;/sub&gt; were also assessed.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;MetS&lt;sub&gt;IFG&lt;/sub&gt; and MetS&lt;sub&gt;HOMA-IR&lt;/sub&gt; point prevalences were both 0.3% in the healthy weight group; they were 2.6% and 5.9%, respectively, in the overweight group and were 22.9% and 35.1%, respectively, in the obese group (P &lt; .05 for both). An IFG threshold of 100 mg/dL or higher was found in 1.0% of participants, whereas a HOMA-IR of 3.99 or higher was found in 19.5% of participants.&lt;div class="boxTitle"&gt;Conclusions&lt;/div&gt;An elevated HOMA-IR is much more sensitive than an IFG threshold in identifying adolescents with metabolic dysregulation. Using a HOMA-IR threshold of 3.99 identifies more youth with MetS than using an IFG threshold of 100 mg/dL. In addition to increasing the sensitivity of MetS detection, HOMA-IR has a much higher association with the other MetS components than the IFG threshold and may better reflect a unified underlying pathologic process useful to identify youth at risk for disease.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">166</prism:volume>
      <prism:number xmlns:prism="prism">11</prism:number>
      <prism:startingPage xmlns:prism="prism">1030</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">1036</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/archpediatrics.2012.1263</prism:doi>
      <guid>http://archpedi.jamanetwork.com/article.aspx?articleID=1362181</guid>
    </item>
  </channel>
</rss>